Adriane Arnold, APRN
Family · Overland Park, KSNPI 1467945618
Payments from drug & device makers
Across 134 payments — averaging $31.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- AbbVie$737
- Ferring Pharmaceuticals Inc.$385
- Ipsen Biopharmaceuticals, Inc$350
- Amgen$205
- Averitas Pharma Inc.$179
- plus $827 from 16 others
Across 1 payment — averaging $1650.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Travel & lodging$1,21229%
- Food & beverage$2,94871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 11 | $1,477 |
| AbbVie(2 entities) | 44 | $737 |
| Ferring Pharmaceuticals Inc. | 21 | $385 |
| Ipsen Biopharmaceuticals, Inc | 18 | $350 |
| Amgen | 4 | $205 |
| Averitas Pharma Inc. | 5 | $179 |
| Piramal Critical Care | 1 | $121 |
| Medtronic | 5 | $106 |
| GRT US Holding, Inc. | 1 | $104 |
| Merz Pharmaceuticals, LLC | 3 | $83 |
| Bioventus LLC | 4 | $69 |
| Acumed LLC | 1 | $58 |
| Vertex | 3 | $51 |
| Upsher-smith Laboratories LLC | 2 | $43 |
| Revance Therapeutics, Inc. | 2 | $40 |
| Pfizer | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Radius Health, Inc. | 1 | $27 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,159 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 17 | $11,702 |
| Baclofen | 73 | $2,066 |
| Gabapentin | 40 | $466 |
| RizatriptanRizatriptan Benzoate | 11 | $299 |
| Clonazepam | 12 | $276 |
| Tizanidine Hcl | 36 | $246 |
| Celecoxib | 15 | $0 |
Paid to pharmacies, not to this prescriber.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.